Items where Author is "Regad, T"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 30.

AL-JUBOORI, S.I.K., VADAKEKOLATHU, J., IDRI, S., WAGNER, S., ZAFEIRIS, D., PEARSON, J.R.D., ALMSHAYAKHCHI, R., CARAGLIA, M., DESIDERIO, V., MILES, A.K., BOOCOCK, D.J., BALL, G.R. and REGAD, T., 2019. PYK2 promotes HER2-positive breast cancer invasion. Journal of Experimental & Clinical Cancer Research, 38: 210. ISSN 1756-9966

MELE, L., LA NOCE, M., PAINO, F., REGAD, T., WAGNER, S., LICCARDO, D., PAPACCIO, G., LOMBARDI, A., CARAGLIA, M., TIRINO, V., DESIDERIO, V. and PAPACCIO, F., 2019. Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation. Journal of Experimental & Clinical Cancer Research, 38: 160. ISSN 1756-9966

BARBATO, L., BOCCHETTI, M., DI BIASE, A. and REGAD, T., 2019. Cancer stem cells and targeting strategies. Cells, 8 (8), p. 926. ISSN 2073-4409

VADAKEKOLATHU, J., AL-JUBOORI, S.I.K., JOHNSON, C., SCHNEIDER, A., BUCZEK, M.E., DI BIASE, A., POCKLEY, A.G., BALL, G.R., POWE, D.G. and REGAD, T., 2018. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death & Disease, 9: 344. ISSN 2041-4889

BALAHMAR, R.M., BOOCOCK, D.J., COVENEY, C., RAY, S., VADAKEKOLATHU, J., REGAD, T., ALI, S. and SIVASUBRAMANIAM, S., 2018. Identification and characterisation of NANOG+/OCT-4high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines. Oncotarget. ISSN 1949-2553

DI BIASE, A., MILES, A.K. and REGAD, T., 2018. Generation of in vitro model of epithelial mesenchymal transition (EMT) via the expression of a cytoplasmic mutant form of promylocytic leukemia protein (PML). In: G. PAPACCIO and V. DESIDERIO, eds., Cancer stem cells. Methods in molecular biology (1692). New York: Humana Press, pp. 129-138. ISBN 9781493974009

LA NOCE, M., PAINO, F., MELE, L., PAPACCIO, G., REGAD, T., LOMBARDI, A., PAPACCIO, F., DESIDERIO, V. and TIRINO, V., 2018. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy. Journal of Experimental & Clinical Cancer Research, 37 (1): 296. ISSN 1756-9966

BUCZEK, M.E., REEDER, S.P. and REGAD, T., 2018. Identification and isolation of cancer stem cells using NANOG-EGFP reporter system. In: G. PAPACCIO and V. DESIDERIO, eds., Cancer stem cells. Methods in molecular biology (1692). New York: Humana Press, pp. 139-148. ISBN 9781493974009

MELE, L., PAINO, F., PAPACCIO, F., REGAD, T., BOOCOCK, D., STIUSO, P., LOMBARDI, A., LICCARDO, D., AQUINO, G., BARBIERI, A., ARRA, C., COVENEY, C., LA NOCE, M., PAPACCIO, G., CARAGLIA, M., TIRINO, V. and DESIDERIO, V., 2018. A new inhibitor of glucose-6-phospate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo. Cell Death & Disease, 9: 572. ISSN 2041-4889

PAPACCIO, F., PAINO, F., REGAD, T., PAPACCIO, G., DESIDERIO, V. and TIRINO, V., 2017. Concise review: cancer cells, cancer stem cells, and mesenchymal stem cells: influence in cancer development. Stem Cells Translational Medicine. ISSN 2157-6564

PEARSON, J.R.D. and REGAD, T., 2017. Targeting cellular pathways in glioblastoma multiforme. Signal Transduction and Targeted Therapy, 2, e17040. ISSN 2059-3635

REGAD, T., 2017. Tissue-specific cancer stem cells: reality or a mirage? Translational Medicine Reports, 1 (6535), pp. 24-26.

BUCZEK, M.E., MILES, A.K., GREEN, W., JOHNSON, C., BOOCOCK, D.J., POCKLEY, A.G., REES, R.C., HULMAN, G., VAN SCHALKWYK, G., PARKINSON, R., HULMAN, J., POWE, D.G. and REGAD, T., 2016. Cytoplasmic PML promotes TGF-β-associated epithelial–mesenchymal transition and invasion in prostate cancer. Oncogene, 35, pp. 3465-3475. ISSN 0950-9232

DVORKINA, M., NIEDDU, V., CHAKELAM, S., PEZZOLO, A., CANTILENA, S., LEITE, A.P., CHAYKA, O., REGAD, T., PISTORIO, A., SEMENTA, A.R., VIRASAMI, A., BARTON, J., MONTANO, X., LECHERTIER, T., BRINDLE, N., MORGENSTERN, D., LE BRAS, M., BURNS, A., SAUNDERS, N., HODIVALA-DILKE, K., BAGELLA, L., DE THE, H., ANDERSON, J., SEBIRE, N., PISTOIA, V., SALA, A. and SALOMONI, P., 2016. A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma. Clinical Cancer Research, 22 (13), pp. 3398-3409. ISSN 1078-0432

REGAD, T., SAYERS, T.J. and REES, R.C., 2015. Principles of stem cell biology and cancer: future applications and therapeutics. Oxford: Wiley-Blackwell. ISBN 9781118670620

BUCZEK, M.E., EDWARDS, J.C. and REGAD, T., 2015. Prostate cancer and prostate cancer stem cells. In: T. REGAD, T.J. SAYERS and R.C. REES, eds., Principles of stem cell biology and cancer: future applications and therapeutics. Oxford: Wiley-Blackwell, pp. 193-212. ISBN 9781118670620

REGAD, T., 2015. Targeting RTK signaling pathways in cancer. Cancers, 7 (3), pp. 1758-1784. ISSN 2072-6694

REGAD, T. and MATHIEU, M.G., 2014. Cancer Stem Cells (CSCs) and Epithelial-to-Mesenchymal Transition (EMT): tumor cell plasticity challenges immunotherapy. In: R.C. REES, ed., Tumor immunology and immunotherapy. Oxford: Oxford University Press. ISBN 9780199676866

MATHIEU, M.G., MILES, A.K., AHMAD, M., BUCZEK, M.E., POCKLEY, A.G., REES, R.C. and REGAD, T., 2014. The helicase HAGE prevents interferon-a-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death and Disease, 5 (2). ISSN 2041-4889

MATHIEU, M.G., MILES, A.K., AHMAD, M., BUCZEK, M.E., POCKLEY, A.G., REES, R.C. and REGAD, T., 2014. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death & Disease, 5 (2). ISSN 2041-4889

REGAD, T., 2013. Molecular and cellular pathogenesis of melanoma initiation and progression. Cellular and Molecular Life Sciences, 70 (21), pp. 4055-4065. ISSN 1420-682X

REGAD, T., 2012. Role et devenir des corps nucleaires PML lors des infections virales: PML, un nouvel intermédiaire de l'effet antiviral de l'interféron. Presses Académiques Francophones. ISBN 9780199676866

LINLEY, A.J., MATHIEU, M.G., MILES, A.K., REES, R.C., MCARDLE, S.E.B. and REGAD, T., 2012. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tunor cell proliferation in vivo. Journal of Biological Chemistry, 287 (17), pp. 13633-13643.

REGAD, T., EL, M., MAROUI, M.A., RODRIGUEZ, M.S., AMINEV, A., GERBAUD, S., ESCRIOU, N., DIANOUX, L. and CHELBI-ALIX, M.K., 2010. SUMOylation promotes PML degradation during encephalomyocarditis virus infection. Journal of Virology, 84 (22), pp. 11634-11645. ISSN 0022-538X

REGAD, T., BELLODI, C., NICOTERA, P. and SALOMONI, P., 2009. The tumour suppressor Pml regulates cell fate in the developing neocortex. Nature Neuroscience, 12 (2), pp. 132-140.

REGAD, T., ROTH, M., BREDENKAMP, N., ILLING, N. and PAPALOPULU, N., 2007. The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF. Nature Cell Biology, 9 (5), pp. 531-540.

REGAD, T. and CHELBI-ALIX, M.K., 2002. PML, a mediator of interferon-induced antiviral response [in French; PML, un nouvel intermédiaire de l'effet antiviral de l'interféron]. Médecine/Sciences: M/S, 18 (1), pp. 25-27. ISSN 0767-0974

BLONDEL, D., REGAD, T., POISSON, N., PAVIE, B., HARPER, F., PANDOLFI, P.P., DE, T. and CHELBI-ALIX, M.K., 2002. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene, 21 (52), pp. 7957-7970. ISSN 0950-9232

REGAD, T., SAIB, A., LALLEMAND-BREITENBACH, V., PANDOLFI, P.P., DE, T. and CHELBI-ALIX, M.K., 2001. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. The EMBO Journal, 20 (13), pp. 3495-3505. ISSN 0261-4189

REGAD, T. and CHELBI-ALIX, M.K., 2001. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene, 20 (49), pp. 7274-7286. ISSN 0950-9232

This list was generated on Mon Nov 29 08:25:18 2021 UTC.